ALKOHOLBEHANDLING - Statens Institut for Folkesundhed

159
de Sousa A. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol
2004; 39(6):528-531.
160
de Sousa A, de Sousa A. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol
dependence. Alcohol Alcohol 2005; 40(6):545-548.
161
Alho H, Laaksonen E. A randomized, comparative study of ovendence-based alcohol dependence treatments: Disulfiram,
naltresone, and acamprosate in the treatment of alcohol dependence. London, UK: The Stapleford Centre, 2006.
162
Johnsen J, Stowell A, Bache-Wiig JE, Stensrud T, Ripel A, Morland J. A double-blind placebo controlled study of male
alcoholics given a subcutaneous disulfiram implantation. Br J Addict 1987; 82(6):607-613.
163
Johnsen J, Morland J. Disulfiram implant: a double-blind placebo controlled follow-up on treatment outcome. Alcohol
Clin Exp Res 1991; 15(3):532-536.
164
Johnsen J, Morland J. Depot preparations of disulfiram: experimental and clinical results. Acta Psychiatr Scand Suppl 1992;
369:27-30.
165
Wilson A, Davidson WJ, Blanchard R, White J. Disulfiram implantation. A placebo-controlled trial with two-year followup.
J Stud Alcohol 1978; 39(5):809-819.
166
De Witte P, Littleton J, Parot P, Koob G. Neuroprotective and abstinence-promoting effects of acamprosate: elucidating
the mechanism of action. CNS Drugs 2005; 19(6):517-537.
167
Chick J, Howlett H, Morgan MY, Ritson B. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective
study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 2000;
35(2):176-187.
168
Mason BJ, Goodman AM, Dixon RM, Hameed MH, Hulot T, Wesnes K et al. A pharmacokinetic and pharmacodynamic
drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology: official publication of the American
College of Neuropsychopharmacology 2002; 27(4):596-606.
169
Gual A, Lehert P. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in
Spain. Alcohol Alcohol 2001; 36(5):413-418.
170
Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin
Exp Res 2001; 25(9):1335-1341.
171
Poldrugo F. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Addiction 1997;
92(11):1537-1546.
172
Sass H, Soyka M, Mann K, Zieglgansberger W. Relapse prevention by acamprosate. Results from a placebo-controlled
study on alcohol dependence. Arch Gen Psychiatry 1996; 53(8):673-680.
173
Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz T et al. Comparison of acamprosate and
placebo in long-term treatment of alcohol dependence. Lancet 1996; 347(9013):1438-1442.
174
Bouza C, Angeles M, Munoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol
dependence: a systematic review. Addiction 2004; 99(7):811-828.
175
Mann K, Lehert P, Morgan M. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent
individuals: results of a meta-analysis. Alcohol Clin Exp Res 2004; 28(1):51-63.
Alkoholbehandling – en medicinsk teknologivurdering 114